AB Soft ii manual

Cooperative Oncology Group. Ann Oncol 16(6): 972-980, 6/2005.

11.Du Pen SL, Du Pen AR, Polissar N, Hansberry J, Kraybill BM, Stillman M, Panke J, Everly R, Syrjala K. Implementing guidelines for cancer pain management: results of a randomized controlled clinical trial. J Clin Oncol 17(1): 361- 370, 1/1999.

12.Elliott BA, Elliott TE, Murray DM, Braun BL, Johnson KM. Patients and family members: the role of knowledge and attitudes in cancer pain. J Pain Symptom Manage 12(4): 209-220, 10/1996.

13.Esnaola NF, Cantor SB, Johnson ML, Mirza AN, Miller AR, Curley SA, Crane CH, Cleeland CS, Janjan NA, Skibber JM. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol 20(21): 4361-4367, 11/2002.

14.Ferrell BR, Grant MM, Funk BM, Otis-Green SA, Garcia NJ. Quality of life in breast cancer survivors: implications for developing support services. Oncol Nurs Forum 25(5): 887-895, 6/1998.

15.Gabrail NY, Dvergsten C, Ahdieh H. Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study. Curr Med Res Opin 20(6): 911- 918, 6/2004.

16.Gulluoglu BM, Cingi A, Cakir T, Gercek A, Barlas A, Eti Z. Factors related to post-treatment chronic pain in breast cancer survivors: the interference of pain with life functions. Int J Fertil Womens Med 51(2): 75-82, 3/2006.

17.Holtan A, Kongsgaard UE, Ohnstad HO. [Cancer pain in hospitalized patients]. Tidsskr Nor Laegeforen 125(4): 416-418, 2/2005.

18.Holtan A, Kongsgaard UE, Haugen DF. Episodic pain in hospitalized cancer patients. European Journal of Pain 10(Supplement 1): S247, 9/2006.

19.Hsu TH, Lu MS, Tsou TS, Lin CC. The relationship of pain, uncertainty, and hope in Taiwanese lung cancer patients. J Pain Symptom Manage 26(3): 835-842, 9/2003.

20.Huang HY, Wilkie DJ, Chapman CR, Ting LL. Pain trajectory of Taiwanese with nasopharyngeal carcinoma over the course of radiation therapy. J Pain Symptom Manage 25(3): 247-255, 3/2003.

21.Hwang SS, Chang VT, Fairclough DL, Kasimis B. Development of a cancer pain prognostic scale. J Pain Symptom Manage 24(4): 366-378, 10/2002.

22.Hwang SS, Chang VT, Kasimis B. Cancer breakthrough pain characteristics and responses to treatment at a VA medical center. Pain 101(1-2): 55-64, 1/2003.

23.Kashikar-Zuck S, Keefe FJ, Kornguth P, Beaupre P, Holzberg A, Delong D. Pain coping and the pain experience during mammography: a preliminary study. Pain 73(2): 165-172, 11/1997.

24.Klepstad P, Borchgrevink PC, Dale O, Zahlsen K, Aamo T, Fayers P, Fougner B, Kaasa S. Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients. Palliat Med 17(8): 679-687, 12/2003.

25.Konski A, DeSilvio M, Hartsell W, Watkins-Bruner D, Coyne J, Scarantino C, JanJan N. Continuing evidence for poorer treatment outcomes for single male patients: Retreatment data from RTOG 97-14. Int J Radiat Oncol Biol Phys 66(1): 229- 233, 9/2006.

26.Lai YH, Guo SL, Keefe FJ, Tsai SL, Chien CC, Sung YC, Chen ML. Effects of brief pain education on hospitalized cancer patients with moderate to severe pain. Support Care Cancer 12(9): 645-652, 9/2004.

27.Leppert W. Controlled release dihydrocodeine and tramadol in cancer pain treatment-Polish experience. Eur J Pain 10(Supplement 1): S147, 9/2006.

23 24